On August 11, 2026, Cardinal Health Reported Q4 Revenue Up Nearly 6% to $6.367 Billion
On August 11, 2026, Cardinal Health reported fiscal fourth-quarter revenue of $6.367 billion for the period ended June 30, up nearly 6% year over year. Shares rose over 1% to a record closing high, after touching an intraday high of $258.30. The global medical products and distribution segment posted revenue of $3.13 billion, slightly lower, with segment profit of $150 million including a $100 million tariff refund. Other segments, including nuclear and precision health, home solutions, and OptiFreight, grew 7% to $1.72 billion, with a segment margin of 10.6%.
Shares of the company rose more than 1% on the day, touching an intraday record high of $258.30 before paring gains, and closed at a record high. The previous record closing high was $239.71 set on July 7, and the previous intraday record high was $244.01 on August 6.
This segment covers brand and generic drug distribution, specialty drug distribution, hospital pharmacy management services, and medical business management organizations. The global medical products and distribution segment reported revenue of $3.13 billion, down slightly year over year, partly due to the recognition of tariff refunds. The segment's profit of $150 million included a $100 million refund benefit. Other segments, which include nuclear and precision health solutions, home solutions, and OptiFreight logistics, grew 7% year over year to $1.72 billion, with a segment margin of 10.6%, significantly higher than the roughly 1% margin of the other two segments.